71 related articles for article (PubMed ID: 8303884)
1. [Antibodies to the structural proteins of the measles virus studied in some chronic diseases].
Nikolaeva LI; Bogomolova NN; Filimonova RG; Borisova VV; Tikhonova NT; Mamaeva TA; Naumova MA
Vopr Virusol; 1993; 38(6):256-8. PubMed ID: 8303884
[TBL] [Abstract][Full Text] [Related]
2. IgM antibodies in sera from patients with chronic active hepatitis reacting with the measles virus matrix protein and nucleoprotein.
Christie KE; Endresen C; Haukenes G
J Med Virol; 1984; 14(2):149-57. PubMed ID: 6208319
[TBL] [Abstract][Full Text] [Related]
3. Characterization of measles virus-specific antibodies in sera from patients with chronic active hepatitis.
Christie KE; Endresen C; Haukenes G
J Hyg (Lond); 1982 Jun; 88(3):519-28. PubMed ID: 7045218
[TBL] [Abstract][Full Text] [Related]
4. Lack of cross-reactivity between antibody against smooth muscle and antibodies to measles virus in sera from patients with chronic active hepatitis.
Sommer AI; Haukenes G
J Clin Pathol; 1982 Dec; 35(12):1388-91. PubMed ID: 7174849
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis.
Brinckmann UG; Bankamp B; Reich A; ter Meulen V; Liebert UG
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2491-500. PubMed ID: 1833505
[TBL] [Abstract][Full Text] [Related]
6. [Detection of the measles virus genome in the peripheral blood lymphocytes of patients with chronic and acute glomerulonephritis].
Bogomolova NN; Chaplygina NM; Ataullakhanov AI; Burgasova MP; Nevraeva EG; Filimonova RG
Mol Gen Mikrobiol Virusol; 1990 Oct; (10):26-7. PubMed ID: 1702185
[TBL] [Abstract][Full Text] [Related]
7. Measles virus-specific IgM antibodies in sera from patients with chronic active hepatitis.
Christie KE; Haukenes G
J Med Virol; 1983; 12(4):267-72. PubMed ID: 6655465
[TBL] [Abstract][Full Text] [Related]
8. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization.
de Swart RL; Yüksel S; Osterhaus AD
J Virol; 2005 Sep; 79(17):11547-51. PubMed ID: 16103210
[TBL] [Abstract][Full Text] [Related]
9. Antibody-induced restriction of viral gene expression in measles encephalitis in rats.
Liebert UG; Schneider-Schaulies S; Baczko K; ter Meulen V
J Virol; 1990 Feb; 64(2):706-13. PubMed ID: 2296081
[TBL] [Abstract][Full Text] [Related]
10. Analysis of antibody response to synthetic peptides derived from the fusion protein of measles virus.
Meqdam M; Mostratos A
New Microbiol; 1999 Jan; 22(1):19-25. PubMed ID: 10190113
[TBL] [Abstract][Full Text] [Related]
11. Neutralization enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.
Nates SV; Rey GY; Giordano MO; Depetris AR; Boshell J
Viral Immunol; 1995; 8(1):47-52. PubMed ID: 8546804
[TBL] [Abstract][Full Text] [Related]
12. Measles antibodies in nasal secretions and sera of children with measles.
Polna I; Aleksandrowicz J; Krawczyński K; Krotochwil-Skrzypek M; Rozskowska K
Acta Virol; 1977 Jul; 21(4):331-7. PubMed ID: 20768
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection.
Schlereth B; Germann PG; ter Meulen V; Niewiesk S
J Gen Virol; 2000 May; 81(Pt 5):1321-5. PubMed ID: 10769075
[TBL] [Abstract][Full Text] [Related]
14. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.
Muller CP; Beauverger P; Schneider F; Jung G; Brons NH
J Gen Virol; 1995 Jun; 76 ( Pt 6)():1371-80. PubMed ID: 7782766
[TBL] [Abstract][Full Text] [Related]
15. The significance for epidemiological studies anti-measles antibody detection examined by enzyme immunoassay (EIA) and plaque reduction neutralization test (PRNT).
Siennicka J; Częścik A; Trzcińska A
Przegl Epidemiol; 2014; 68(3):417-20, 527-9. PubMed ID: 25394302
[TBL] [Abstract][Full Text] [Related]
16. Antimeasles immunoglobulin G and virus-neutralizing activity in sera of patients with otosclerosis.
Lolov S; Edrev G; Kyurkchiev S
Adv Otorhinolaryngol; 2007; 65():107-113. PubMed ID: 17245030
[TBL] [Abstract][Full Text] [Related]
17. [The genome of the measles virus in the peripheral blood lymphocytes in kidney diseases].
Bogomolova NN; Filimonova RG; Nevraeva EG; Ataullakhanov AI; Nikolaeva LI; Tashkan SE
Vopr Virusol; 1992; 37(3):173-4. PubMed ID: 1441447
[No Abstract] [Full Text] [Related]
18. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies.
Ong HT; Hasegawa K; Dietz AB; Russell SJ; Peng KW
Gene Ther; 2007 Feb; 14(4):324-33. PubMed ID: 17051248
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
